Objective To characterize the association of carrier lipoproteins, apolipoproteins, triglycerides and various lipid ratios with total cholesterol in young adults.
Design Cross-sectional data from the baseline examination (1985–1986) of The Coronary Artery Risk Development In Young Adults (CARDIA) Study, a multicenter investigation of a biracial cohort of 4941 men and women aged 18–30 years.
Methods Multiple linear regression models to estimate mean levels of lipids and lipoproteins for each category of total cholesterol, stratified by race and sex and adjusted for age and education level.
Results As expected, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), apolipoprotein B (ApoB), apolipoprotein A-I (ApoA-I) and triglycerides increased linearly with the level of total cholesterol in all race-sex subgroups. The LDL-C/HDL-C, ApoB/ApoA-I and LDL-C/ApoB ratio also increased with total cholesterol in all race–sex subgroups. The HDL-C/ApoA-I ratio, indicative of cholesterol content per HDL particle, did not vary with total cholesterol except in white men, in whom it was slightly lower for those with high total cholesterol than those with low total cholesterol concentrations. White men showed higher triglyceride concentrations and lower HDL-C for any given total cholesterol strata. All these associations of lipoproteins, apolipoproteins and lipid ratios with total cholesterol were independent of body mass index, smoking status, fitness level and Keys score.
Conclusions Young adults with low total cholesterol have lipoprotein profiles characterized by low atherogenic potential. White men with high total cholesterol levels, compared with other groups, showed a lipid profile more conducive to atherogenesis.
KeysA: Coronary heart disease in seven countriesCirculation1970, 41 (Suppl):1–211.
2.
KannelWBCastelliWPGordonT: Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham StudyAnn Intern Med1979, 90:85–91.
3.
MartinMJHulleySBBrownerWSKullerLHWentworthD: Serum cholesterol, blood pressure and mortality: Implications from a cohort of 361 662 menLancet1986, i:933–936.
4.
KannelWBGordonTCastelliWP: Role of lipids and lipoprotein fractions in assessing atherogenesis. The Framingham StudyProg Lipid Res1981, 20:339–348.
5.
FieldingCJFieldingPE: Cholesterol transport between cells and body fluids. Role of plasma lipoproteins and plasma cholesterol esterification systemMed Clin North Am1982, 66:363–373.
6.
SteinYGlangeaudMCFainaruMSteinO: The removal of cholesterol from aortic smooth muscle cells in culture and Landschutz ascites cells by fractions of human high density apolipoproteinBiochim Biophys Acta1975, 380:106–118.
7.
DonahueRPJacobsDRJrSidneySWagenknechtLEAlbersJJHulleySB: Distribution of lipoproteins and apolipoproteins in young adults. The CARDIA StudyArteriosclerosis1989, 9:656–664.
8.
HughesGHCutterGDonahueRFriedmanGDHulleySHunkelerE: Recruitment in the Coronary Artery Disease Risk Development in Young Adults (CARDIA) StudyControlled Clin Trials1987, 8:68S–73S.
9.
FriedmanGDCutterGRDonahueRPHughesGHHulleySBJacobsDRJr: CARDIA: Study design, recruitment, and some characteristics of the examined subjectsJ Clin Epidemiol1988, 41:1105–1116.
10.
WagenknechtLEBurkeGLPerkinsLLHaleyNJFriedmanGD: Misclassification of smoking status in the CARDIA study: A comparison of self-report with serum cotinine levelsAm J Public Health1992, 82:33–36.
11.
McDonaldAVan HornLSlatteryMHilnerJBraggCCaanB: The CARDIA dietary history: Development and implementationJ Am Diet Assoc1991, 91:1104–1112.
12.
LiuKSlatteryMJacobsDJrCutterGMcDonaldAVan HornL: A study of the reliability and comparative validity of the CARDIA dietary historyEthnicity Dis1994, 4:15–27.
13.
KeysAAndersonJTGrandeF: Serum cholesterol response to changes in diet. IV. Particular saturated fatty acids in the dietMetabolism1965, 14:776–787.
14.
Manual of Laboratory Operations. Lipid Research Clinics Program, Lipid and Lipoprotein Analysis 1Bethesda: National Heart, Lung and Blood Institute; 1974. [DHEW Publication (NIH) 75–628].
15.
WarnickGRBendersonJMAlbersJJBaillieEESextonBSchaeferEJ: Dextran sulfate-Mg2+ precipitation procedure for quantitation of highdensity-lipoprotein cholesterolClin Chem1982, 28:1379–1388.
16.
FriedewaldWTLevyRIFredriksonDS: Estimation of the concentration of the low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifugeClin Chem1972, 18:499–502.
17.
SAS Institute: SAS/STAT User's Guide, 6.09 Edition. Cary, NC: Sas Institute, Inc.; 1994.
18.
SteinbergDParthasarathySCarewTEKhooJCWitztumJL: Beyond cholesterol: Modifications of low-density lipoproteins that increase its atherogenicityN Engl J Med1989, 320:915–924.
19.
AustinMA: Plasma triglyceride and coronary heart diseaseArteriosclerosis1991, 11:2–14.
20.
FrankJWReedDMGroveJSBenfanteR: Will lowering population levels of serum cholesterol affect total mortality? Expectations from the Honolulu Heart ProgramJ Clin Epidemiol1992, 45:333–346.
21.
Davey SmithGShipleyMJMarmotMGRoseG: Plasma cholesterol concentration and mortality: The Whitehall StudyJAMA1992, 267:70–76.
22.
NeatonJDBlackburnHJacobsDKullerLLeeDJSherwinR: Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention TrialArch Intern Med1992, 152:1490–1500.
23.
JacobsDRJrBlackburnHHigginsMReedDIsoHMcMillanG: Report of the conference on low blood cholesterol: Mortality associationsCirculation1992, 86:1046–1060.
24.
JacobsDRJrMuldoonMFRístamL: Invited commentary: Low blood cholesterol, nonillness mortality, and other nonatherosclerotic disease mortality: A search for causes and confoundersAm J Epidemiol1995, 141:518–522.
IribarrenCReedDMBurchfielCMDwyerJH: Serum total cholesterol and mortality. Confounding factors and risk modification in Japanese-American menJAMA1995, 273:1926–1932.
27.
IribarrenCReedDMYanoKChenR.DwyerJH: Low cholesterol and mortality: Which is the cause and which is the effect?Circulation1995, 92:2396–2403.
28.
BrownMSGoldsteinJL: A receptor-mediated pathway for cholesterol homeostasisScience1986, 232:34–47.
29.
KesaniemiYAWitztumJLSteinbrecherUP: Receptor-mediated catabolism of low density lipoprotein in manJ Clin Invest1983, 71:950–959.
30.
BrownMSGoldsteinJL: Lipoprotein receptors in the liver: Control signals for plasma cholesterol trafficJ Clin Invest1983, 72:743–747.
31.
BilheimerDWStoneNJGrundySM: Metabolic studies in familial hypercholesterolemiaJ Clin Invest1979, 64:524–533.
